Interestingly, aAbs against the negative regulator of p53, MDM2, have been detected in the serums of patients with lung cancer and autoimmune diseases, namely systemic lupus erythematosus (SLE) and Sjogren’s syndrome [34,35,36]. This evidence concerns the gene TP53 and systemic lupus erythematosus.